1상모집 중

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

연구 개요

The researchers are doing this study is to find the highest dose of cytokine-induced memory-like (CIML) natural killer (NK) cells in combination with the drug atezolizumab that causes few or mild side effects in people with relapsed/refractory acute myelogenous leukemia (AML). The researchers will also look at whether the treatment combination works against participants' cancer.

스폰서: 협력: 로슈
적응증: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse
중재: Cytokine Induced Memory-Like Natural Killer Cells, Atezolizumb, CIML-NK cell therapy
목표 등록: 18명
시작일: 2025-05-30
완료(예정): 2028-05-01
등록번호: NCT07011004 · ClinicalTrials.gov ↗

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.